NCT03060174

Brief Summary

Postoperative cognitive dysfunction describes a condition where cognitive functions such as attention, perception, concentration, learning, abstract thinking and problem solving are impaired postoperatively. These changes can be resolved after weeks and months, but in some cases may be permanent. The aetiology is multifactorial. One risk factor for developing POCD is the occurrence of postoperative delirium. A total of 638 consecutive patients will be enrolled in the study. Patients will be followed up at 7 days, 3 months and 1 year postoperatively. The cognitive function will be tested and compared to tests done before surgery. Postoperatively (from the day of operation until the 7th day and except of day 6) the grade of sedation; agitation; signs of delirium; pain; cardiac; respiratory; renal and infectious complications will be recorded. As possible influencing factors, the investigators will document diagnosed depression; comorbidities; intraoperative blood loss; length of hospital stay; 1-year-mortality; number of operations/anaesthetics undergone after the initial operation. Parameters that could trigger either depressive symptoms, neurocognitive dysfunction, anxiety, fatigue or lack of concentration will be recorded. These include: anaemia, hypercalcaemia, thyroidal gland hormones, electrolytes, creatinine, urea, glomerular filtration rate, cortisone therapy and adrenal cortical insufficiency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
638

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2014

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

October 26, 2021

Status Verified

October 1, 2021

Enrollment Period

4 years

First QC Date

June 16, 2014

Last Update Submit

October 24, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative cognitive deficit (POCD)

    measured by neuropsychological test battery, analysis

    change from baseline in cognitive function at day 7, 3 months and 1 year after operation

Secondary Outcomes (8)

  • incidence and severity of postoperative delirium

    from the day of operation until the 7th postoperative day

  • number of patients with cardiac complications

    day of operation until 7th postoperative day

  • length of hospital stay

    from day of admission until day of discharge, up to 24 weeks

  • mortality

    1 year

  • health related quality of life

    3 months, 1 year after operation

  • +3 more secondary outcomes

Other Outcomes (4)

  • anxiety and depressive symptoms on HADS-D

    7 days, 3 months, 1 year after operation

  • postoperative pain scores on the numeric rating scale (NRS)

    day of operation until 7th postoperative day, 3 months, 1 year after operation

  • haemoglobin (Anaemia) on a score

    intraoperative

  • +1 more other outcomes

Study Arms (2)

monitoring and non-medical prophylaxis of delirium

OTHER

The treatment group will receive monitoring and prophylaxis of delirium. The study arm designed to prevent delirium incorporates reorientation (watches, calendar, family photos, use of hearing aids, glasses and dentures, cognitive stimulation (newspaper, magazines, radio, television), early mobilisation, early enteral nutrition, early removal of drains or catheters, normalizing sleep-awake-rhythm.

Other: monitoring and non-medical prophylaxis of delirium

Standard

NO INTERVENTION

The standard group will receive standard monitoring and standard treatment. The indication, choice and dosage of the medication used to treat delirium will be at the discretion of the ward doctor and will not be influenced by this study. The chosen medication as well as its dosage will be documented.

Interventions

monitoring and non-medical prophylaxis of delirium

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 60 years
  • Cardiac surgery (on-pump/off-pump, standard/minimal invasive)
  • Written informed patient's consent

You may not qualify if:

  • Non-German speaking or not their first language
  • Illiteracy
  • Mental disability
  • Non-corrigible vision impairment
  • Non-corrigible hearing impairment
  • Illegal substance abuse (current or past history)
  • Alcohol abuse (current or past history)
  • Chronic benzodiazepine use
  • Psychosis (current or past history)
  • Parkinson Disease
  • Dementia
  • Multiple sclerosis
  • Epilepsy (current or past history)
  • Cerebral tumor (current or past history)
  • Apoplexy or intracranial bleeding (current or past history)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf, Univ.-Prof. Dr. med. Alwin E. Goetz and Prof. Dr. med. Christian Zoellner

Hamburg, 20246, Germany

Location

MeSH Terms

Conditions

Postoperative Cognitive ComplicationsEmergence Delirium

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsCognitive DysfunctionCognition DisordersNeurocognitive DisordersMental DisordersDeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2014

First Posted

February 23, 2017

Study Start

May 1, 2014

Primary Completion

May 1, 2018

Study Completion

May 1, 2021

Last Updated

October 26, 2021

Record last verified: 2021-10

Locations